Introduction to Cardiovascular Exercise Assessment

Chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary disease (CTEPD) remain significant challenges in modern cardiology and pulmonology. These conditions arise from organized blood clots that obstruct the pulmonary arteries, leading to increased pulmonary vascular resistance and, eventually, right-sided heart failure. For many patients, persistent dyspnea is the primary symptom that reduces quality of life. Traditionally, clinicians have relied on the six-minute walk test (6MWT) and World Health Organization functional class (WHO-FC) to monitor these individuals. However, these tools often fail to capture the complex physiological mechanisms behind exercise intolerance. Recent clinical evidence suggests that implementing Point-of-care CPET in CTEPH management offers a far more granular and objective evaluation of a patient's status. By measuring gas exchange and ventilatory efficiency directly in an outpatient setting, healthcare providers can better understand the functional impact of pulmonary vascular obstruction. This shift toward point-of-care technology allows for a rapid, precise, and highly reproducible assessment of patient health, ensuring that treatment adjustments occur based on physiological data rather than subjective reporting alone. As revascularization techniques continue to evolve, the need for sophisticated yet accessible diagnostic tools has never been greater.

Physiological Markers of Pulmonary Vascular Obstruction

To appreciate the utility of advanced exercise testing, one must understand the unique pathophysiology of chronic thromboembolic disease. In these patients, the anatomical obstruction of pulmonary vessels creates significant dead-space ventilation. This means that parts of the lung are ventilated but not perfused, forcing the respiratory system to work much harder to eliminate carbon dioxide. Consequently, the relationship between minute ventilation and carbon dioxide production, known as the V/VCO2 slope, becomes markedly abnormal. A steepening of this slope is a hallmark of pulmonary vascular disease and serves as a sensitive indicator of ventilatory inefficiency. While the 6MWT provides a general measure of endurance, it does not distinguish whether a patient's limitation is due to cardiac output, pulmonary gas exchange, or skeletal muscle deconditioning. Cardiopulmonary exercise testing (CPET) bridges this gap by providing real-time data on oxygen uptake and carbon dioxide elimination. Specifically, the V/VCO2 slope has emerged as a robust marker for predicting outcomes and assessing the severity of pulmonary hypertension. In an outpatient environment, having access to these metrics through point-of-care systems allows clinicians to identify subtle changes in a patient's condition long before they manifest as a decrease in walking distance or an increase in functional class severity.

Revascularization Strategies: PTE vs BPA

The treatment landscape for CTEPH has expanded significantly with the advancement of pulmonary thromboendarterectomy (PTE) and balloon pulmonary angioplasty (BPA). PTE remains the gold standard for patients with accessible, proximal disease, offering the potential for a near-complete cure by surgically removing obstructive material. On the other hand, BPA has revolutionized care for those with distal, inoperable disease or persistent symptoms following surgery. Both interventions aim to restore pulmonary perfusion and reduce the workload on the right ventricle. However, determining the clinical success of these procedures requires more than just hemodynamic measurements at rest. Patients often report improved breathing during daily activities that are not fully reflected in resting echocardiography or right heart catheterization. Therefore, objective exercise testing becomes essential to validate the success of revascularization. Evidence shows that successful intervention leads to a significant reduction in the V/VCO2 slope, reflecting a restoration of the ventilation-perfusion match. By using Point-of-care CPET in CTEPH post-procedure, multidisciplinary teams can document the physiological recovery of the pulmonary vasculature. This data is vital for tailoring post-operative rehabilitation and managing expectations for long-term functional recovery, especially in complex cases where residual disease might still exist.

Integrating Point-of-Care CPET in CTEPH Management

One of the primary barriers to widespread CPET usage has been the logistical complexity of traditional laboratory-based systems. These often require specialized technicians, large equipment, and extensive calibration. The introduction of point-of-care systems, such as the SHAPE-HF system, has dismantled these barriers. These compact, outpatient-friendly devices allow for rapid assessment of gas exchange without the need for maximal exertion protocols that can be taxing for fragile patients. In the context of a busy clinical practice, the ability to perform a submaximal exercise test and receive immediate data on ventilatory efficiency is invaluable. Clinicians can use these systems to monitor the iterative improvements seen across multiple sessions of BPA, which often requires several staged procedures. Moreover, the point-of-care approach facilitates more frequent monitoring, allowing for a proactive rather than reactive management strategy. If a patient's ventilatory efficiency plateaus or worsens, it may indicate the need for further intervention or a change in pharmacological therapy. This level of precision medicine ensures that every patient receives an optimized care plan based on their specific physiological response to treatment, ultimately leading to better long-term survival and quality of life.

Analyzing Clinical Study Outcomes

A prospective single-center study recently evaluated sixty patients to determine the impact of revascularization on CPET-derived parameters. Among these, fifty-two patients underwent either PTE or BPA, while eight served as controls. The primary endpoint was the change in the V/VCO2 slope, representing ventilatory efficiency. The results were striking: the average V/VCO2 slope improved from 43 to 31 following intervention, a change that was statistically significant with a P-value of less than 0.001. This improvement in gas exchange efficiency was accompanied by significant gains in the six-minute walk distance and an improvement in WHO functional class. Interestingly, the study highlighted that CPET could detect improvements even when other measures remained relatively stable. This suggests that ventilatory efficiency is a more sensitive marker for the early physiological benefits of revascularization than traditional endurance tests. Furthermore, the study demonstrated that the point-of-care system was both feasible and reliable in a real-world outpatient setting. For clinicians, these findings reinforce the idea that exercise physiology should be a central component of the evaluation process for thromboembolic disease. The ability to quantify the reduction in dead-space ventilation provides a direct measure of the procedure's efficacy on the pulmonary microcirculation.

Clinical Implications and Future Directions

The move toward objective, point-of-care physiological assessment represents a significant milestone in the management of pulmonary vascular diseases. As we look to the future, the integration of Point-of-care CPET in CTEPH care pathways is likely to become a standard recommendation in international guidelines. For Indian clinicians, where the burden of venous thromboembolism is substantial and access to specialized surgical centers is growing, these tools can help bridge the gap in diagnostic capabilities. By utilizing submaximal exercise testing, doctors can safely evaluate patients across a wide spectrum of disease severity. Additionally, this technology holds promise for the early detection of CTEPH in patients who suffer from persistent dyspnea after an acute pulmonary embolism, a condition known as 'post-PE syndrome.' Identifying these patients early through abnormal ventilatory efficiency can lead to faster referrals and better outcomes. As digital health and portable diagnostics continue to improve, the precision with which we monitor chronic disease will only increase. Ultimately, the goal is to ensure that every patient with CTEPD or CTEPH can achieve their maximum functional potential through a combination of timely intervention and rigorous, data-driven follow-up. This study serves as a powerful reminder that when we measure what truly matters to the patient—their ability to breathe during exertion—we can provide more meaningful and effective care.

Frequently Asked Questions

What makes the V/VCO2 slope a critical metric in CTEPH?

The V/VCO2 slope is essential because it directly measures ventilatory efficiency, which is often severely compromised in CTEPH due to pulmonary vascular obstruction. Unlike traditional endurance tests, this metric quantifies the mismatch between ventilation and perfusion. A high slope indicates significant dead-space ventilation, meaning the patient must breathe excessively to maintain normal carbon dioxide levels. Monitoring this slope allows clinicians to objectively track how well revascularization procedures like BPA or PTE are restoring blood flow to the lungs.

How does the point-of-care SHAPE-HF system enhance outpatient clinics?

The SHAPE-HF system provides a compact, user-friendly alternative to traditional, complex CPET laboratories. It allows clinicians to perform gas exchange analysis in a standard outpatient setting without requiring a full team of exercise physiologists. The system focuses on submaximal exercise, making it safer and more tolerable for patients with significant heart or lung disease. By providing immediate data on ventilatory efficiency, it enables rapid clinical decision-making and more frequent monitoring of treatment responses throughout the patient's care journey.

Why is CPET preferred over the 6-minute walk test for treatment evaluation?

While the 6-minute walk test is a valuable measure of overall functional capacity, it is highly dependent on patient effort and can be influenced by non-pulmonary factors like musculoskeletal issues. In contrast, CPET provides objective data on the specific physiological causes of exercise limitation. It distinguishes between cardiac, pulmonary, and peripheral factors by measuring gas exchange. This precision is vital for evaluating the success of revascularization, as it confirms whether the intervention has actually improved the underlying pulmonary vascular physiology.

Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or to replace the professional judgment of a healthcare provider. Readers should always consult with a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.

References

Oliveros E et al. Outpatient Point-of-Care Cardiopulmonary Exercise Testing in Chronic Thromboembolic Pulmonary Disease: A Single-Center Experience. JACC Adv. 2026 Jun 29. doi: undefined. PMID: 42372347.

Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation. 2014;130(6):508-18.

Ghofrani HA, D'Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369(4):319-29.